Myomo (MYO) Non-Current Deferred Tax Liability (2024)
Myomo posted quarterly Non-Current Deferred Tax Liability of $1.9 million for Q4 2024.
Myomo (MYO) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 million in Q4 2024.
- For the quarter ending Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2024 stood at $1.9 million (changed N/A YoY), and the FY2024 full-year result was $1.9 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q4 2024 stood at $1.9 million.
- Across five years, Non-Current Deferred Tax Liability topped out at $1.9 million in Q4 2024 and bottomed at $1.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.87 Mn |
| Dec 31, 2024 | 1.87 Mn |